PUBLISHER: Grand View Research | PRODUCT CODE: 2132501
PUBLISHER: Grand View Research | PRODUCT CODE: 2132501
The global veterinary injectables market size was valued at USD 23.7 billion in 2025 and is projected to grow from USD 25.6 billion in 2026 to USD 46.5 billion by 2033, at 8.9% CAGR from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 35.2% in 2025. The market growth is driven by increasing demand for injectable antibiotics, vaccines, analgesics, anti-inflammatory drugs, anesthetics, and other therapeutic products across companion and production animals.
Rising prevalence of parasiticides, increasing livestock production, and greater adoption of preventive veterinary care support the demand for injectable treatments in the veterinary injectables industry. Moreover, technological advancements in long-acting formulations, injectable biologics, drug delivery systems, formulation development, and sterile manufacturing are improving treatment duration, dosing efficiency, product stability, and manufacturing scalability.
Global Veterinary Injectables Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary injectables market report based on product, animal, therapeutic area, dosage form, route of administration, drug type, distribution channel, and region: